For over three decades, CEI has advocated health care reforms that put more power in the hands of consumers to choose their health providers, treatment protocols, and scope of insurance coverage. We have advocated reform of the Food and Drug Administration’s drug and device approval process to allow for greater flexibility and patient choice. And in 2013, CEI organized the court challenges to Obamacare’s exchange subsidies that concluded with the Supreme Court’s King v. Burwell decision.
Healthcare Issue Areas
Featured Posts
Blog
Market-oriented reforms that can save Medicare $100 billion
Since 1970, Medicare spending has grown from 0.7 percent of GDP to 4.0 percent of GDP, and it is projected to grow even further.
Blog
This week in health care policy: October 16–23, 2026
Medical innovation FDA approves several innovative treatments. Last week, the FDA granted accelerated approval to GSK’s Jemperli for certain untreated…
Blog
This week in health care policy: October 8–15, 2026
Innovation watch Merck expects faster production of its personalized cancer vaccine. CEO Rob Davis told CNBC the six-week turnaround for…
Search Posts
Blog
CDC Says It Is Safe for Vaccinated People to Unmask Outdoors
After much anticipation, the Centers for Disease Control and Prevention (CDC) has finally relaxed its guidelines on mask wearing—people who have been vaccinated…
Blog
A Menthol Cigarette Ban Would Perpetuate the Racist War on Drugs
In April the White House announced an apparently historic shift in the U.S. War on Drugs—away from strict prohibition to an approach emphasizing…
Blog
Democrats’ Drug Price Control Bill Is a Prescription for Disaster
Last Thursday, House Democrats reintroduced a bill from the last Congress, which they claim will protect Medicare from excessive prescription drug prices. Sadly,…
C-SPAN
VIDEO: CEI’s Joel Zinberg joins C-SPAN to Discuss Vaccine Passports and Mandates
Senior Fellow Joel Zinberg joined C-SPAN to discuss the debate over COVID-19 vaccine passports and the role of government and the private sector:…
New York Post
The Feds’ Foolish J&J Vax Pause is Already Undermining the War on COVID
A little more than a week ago, federal officials called for a pause in the use of Johnson & Johnson’s COVID-19 vaccine. The decision…
News Release
House-passed SAFE Banking Act Would End Federal Threat to Banks Dealing with Legal Cannabis Businesses
The House has passed a bill allowing banks to do business with cannabis companies, the SAFE Banking Act. While Senate action on the…